Azacitidine - CaLiGraph

CaLiGraph

Property	Value
rdf:type	owl:NamedIndividual Lactam Orphan drug Nucleoside Triazine Antineoplastic agent Chemotherapeutic agent Suspected male-mediated teratogen IARC Group 2A carcinogen
rdfs:label	Azacitidine
owl:sameAs	dbr:Azacitidine
prov:wasDerivedFrom	http://en.wikipedia.org/wiki/Category:IARC_Group_2A_carcinogens http://en.wikipedia.org/wiki/Category:Orphan_drugs http://en.wikipedia.org/wiki/List_of_drugs:_As%E2%80%93Az http://en.wikipedia.org/wiki/List_of_antineoplastic_agents http://en.wikipedia.org/wiki/List_of_chemotherapeutic_agents http://en.wikipedia.org/wiki/Category:Lactams http://en.wikipedia.org/wiki/Category:Triazines http://en.wikipedia.org/wiki/Category:Nucleosides http://en.wikipedia.org/wiki/IARC_group_2A http://en.wikipedia.org/wiki/Category:Suspected_male-mediated_teratogens
skos:prefLabel	Azacitidine
skos:altLabel	5-azacytidine Azacytidine Vidaza azacitidine azacytidine azaftozine
clgo:alternativeName	Vidaza, Azadine, Onureg
clgo:casNumber	320-67-2
clgo:chEBI	2038
clgo:chEMBL	1489
clgo:drugbank	DB00928
clgo:fdaUniiCode	M801H13NRU
clgo:kegg	D03021
clgo:medlinePlus	a607068
clgo:pubchem	9444
is clgo:medication of	Myelodysplastic syndrome

About: clgr:Azacitidine